Skip to content
Screener

ANI Pharmaceuticals ANIP Unrealized Gain (Loss) on Equity Securities

Unrealized Gain (Loss) on Equity Securities at other companies

Royalty Pharma logo
Royalty PharmaRPRX
-$20.17M+56.0%
EQT Corporation logo
EQT CorporationEQT
$77.51M+193%
Western Digital logo
Western DigitalWDC
$2.73B+551%
Xylem logo
XylemXYL
$0-100%
Atmos Energy logo
Atmos EnergyATO
$43.5K-95.1%
United Airlines Holdings logo
United Airlines HoldingsUAL
-$13M+38.1%

Segments

By segment

See full
Generics and Other$0—
Rare Disease and Brands$0—

Other financials

Income statement

See full
Revenue$266.0M+25.9%
Gross profit$165.9M+21.3%
Operating income$40.5M+191%
Net income$24.7M+189%
EPS (diluted)$1.05+192%

Balance sheet

See full
Cash & equivalents$360.2M+65.4%
Total debt$301.5M-4.2%
Total equity$597.2M+36.7%
Total assets$1.5B+11.3%

Cash flow

See full
Operating cash flow$56.7M-25.3%
CapEx$3.1M-23.9%
Free cash flow$53.6M-25.3%

Valuation

See full
Market cap$1.74B-1.4%
Enterprise value$1.68B-9.6%
P/E16.1×—
P/S1.8×-0.6×

Profitability

See full
Gross margin60.4%-0.7pp
Operating margin15.4%—
Net margin11.1%+10.0pp
FCF margin17.7%+0.9pp

Returns & leverage

See full
Return on equity21%+19.1pp
Debt / equity0.5×-0.2×
Current ratio2.9×+0.4×